Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Antibiotic resistance prediction for Mycobacterium tuberculosis from genome sequence data with Mykrobe.

Hunt M, Bradley P, Lapierre SG, Heys S, Thomsit M, Hall MB, Malone KM, Wintringer P, Walker TM, Cirillo DM, Comas I, Farhat MR, Fowler P, Gardy J, Ismail N, Kohl TA, Mathys V, Merker M, Niemann S, Omar SV, Sintchenko V, Smith G, van Soolingen D, Supply P, Tahseen S, Wilcox M, Arandjelovic I, Peto TEA, Crook DW, Iqbal Z.

Wellcome Open Res. 2019 Dec 2;4:191. doi: 10.12688/wellcomeopenres.15603.1. eCollection 2019.

PMID:
32055708
2.

Epidemiological cut-offs for Sensititre susceptibility testing of Mycobacterium tuberculosis: interpretive criteria cross validated with whole genome sequencing.

Ismail NA, Ismail F, Joseph L, Govender N, Blows L, Kaniga K, Omar SV.

Sci Rep. 2020 Jan 23;10(1):1013. doi: 10.1038/s41598-020-57992-x.

3.

Validation of Bedaquiline Phenotypic Drug Susceptibility Testing Methods and Breakpoints: A Multi-Laboratory, Multi-Country Study.

Kaniga K, Aono A, Borroni E, Cirillo DM, Desmaretz C, Hasan R, Joseph L, Mitarai S, Shakoor S, Torrea G, Ismail NA, Omar SV.

J Clin Microbiol. 2020 Jan 22. pii: JCM.01677-19. doi: 10.1128/JCM.01677-19. [Epub ahead of print]

4.

Pre-detection history of extensively drug-resistant tuberculosis in KwaZulu-Natal, South Africa.

Brown TS, Challagundla L, Baugh EH, Omar SV, Mustaev A, Auld SC, Shah NS, Kreiswirth BN, Brust JCM, Nelson KN, Narechania A, Kurepina N, Mlisana K, Bonneau R, Eldholm V, Ismail N, Kolokotronis SO, Robinson DA, Gandhi NR, Mathema B.

Proc Natl Acad Sci U S A. 2019 Nov 12;116(46):23284-23291. doi: 10.1073/pnas.1906636116. Epub 2019 Oct 28.

5.

Social mixing and clinical features linked with transmission in a network of extensively drug-resistant (XDR) tuberculosis cases in KwaZulu-Natal, South Africa.

Nelson KN, Jenness SM, Mathema B, Lopman BA, Auld SC, Shah NS, Brust JCM, Ismail N, Omar SV, Brown TS, Allana S, Campbell A, Moodley P, Mlisana K, Gandhi NR.

Clin Infect Dis. 2019 Jul 12. pii: ciz636. doi: 10.1093/cid/ciz636. [Epub ahead of print]

PMID:
31342067
6.

In Vitro Study of Stepwise Acquisition of rv0678 and atpE Mutations Conferring Bedaquiline Resistance.

Ismail N, Ismail NA, Omar SV, Peters RPH.

Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e00292-19. doi: 10.1128/AAC.00292-19. Print 2019 Aug.

7.

Multicentre study to establish interpretive criteria for clofazimine drug susceptibility testing.

Ismail NA, Said HM, Rodrigues C, Omar SV, Ajbani K, Sukhadiad N, Kohl TA, Niemann S, Kranzer K, Diels M, Rigouts L, Rüsch-Gerdes S, Siddiqi S.

Int J Tuberc Lung Dis. 2019 May 1;23(5):594-599. doi: 10.5588/ijtld.18.0417.

PMID:
31097068
8.

Linezolid resistance in patients with drug-resistant TB and treatment failure in South Africa.

Wasserman S, Louw G, Ramangoaela L, Barber G, Hayes C, Omar SV, Maartens G, Barry C, Song T, Meintjes G.

J Antimicrob Chemother. 2019 Aug 1;74(8):2377-2384. doi: 10.1093/jac/dkz206.

9.

Whole genome sequencing for drug resistance determination in Mycobacterium tuberculosis.

Omar SV, Joseph L, Said HM, Ismail F, Ismail N, Gwala TL, Ismail NA.

Afr J Lab Med. 2019 Feb 21;8(1):801. doi: 10.4102/ajlm.v8i1.801. eCollection 2019.

10.

Clofazimine Exposure In Vitro Selects Efflux Pump Mutants and Bedaquiline Resistance.

Ismail N, Peters RPH, Ismail NA, Omar SV.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e02141-18. doi: 10.1128/AAC.02141-18. Print 2019 Mar.

11.

Drug resistant tuberculosis in Africa: Current status, gaps and opportunities.

Ismail N, Ismail F, Omar SV, Blows L, Gardee Y, Koornhof H, Onyebujoh PC.

Afr J Lab Med. 2018 Dec 6;7(2):781. doi: 10.4102/ajlm.v7i2.781. eCollection 2018.

12.

Diagnostic strategies for childhood tuberculosis in the context of primary care in a high burden setting: the value of alternative sampling methods.

Hanrahan CF, Dansey H, Mutunga L, France H, Omar SV, Ismail N, Bassett J, Van Rie A.

Paediatr Int Child Health. 2019 May;39(2):88-94. doi: 10.1080/20469047.2018.1533321. Epub 2018 Oct 31.

PMID:
30378470
13.

Collated data of mutation frequencies and associated genetic variants of bedaquiline, clofazimine and linezolid resistance in Mycobacterium tuberculosis.

Ismail N, Omar SV, Ismail NA, Peters RPH.

Data Brief. 2018 Sep 24;20:1975-1983. doi: 10.1016/j.dib.2018.09.057. eCollection 2018 Oct.

14.

Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing.

CRyPTIC Consortium and the 100,000 Genomes Project, Allix-Béguec C, Arandjelovic I, Bi L, Beckert P, Bonnet M, Bradley P, Cabibbe AM, Cancino-Muñoz I, Caulfield MJ, Chaiprasert A, Cirillo DM, Clifton DA, Comas I, Crook DW, De Filippo MR, de Neeling H, Diel R, Drobniewski FA, Faksri K, Farhat MR, Fleming J, Fowler P, Fowler TA, Gao Q, Gardy J, Gascoyne-Binzi D, Gibertoni-Cruz AL, Gil-Brusola A, Golubchik T, Gonzalo X, Grandjean L, He G, Guthrie JL, Hoosdally S, Hunt M, Iqbal Z, Ismail N, Johnston J, Khanzada FM, Khor CC, Kohl TA, Kong C, Lipworth S, Liu Q, Maphalala G, Martinez E, Mathys V, Merker M, Miotto P, Mistry N, Moore DAJ, Murray M, Niemann S, Omar SV, Ong RT, Peto TEA, Posey JE, Prammananan T, Pym A, Rodrigues C, Rodrigues M, Rodwell T, Rossolini GM, Sánchez Padilla E, Schito M, Shen X, Shendure J, Sintchenko V, Sloutsky A, Smith EG, Snyder M, Soetaert K, Starks AM, Supply P, Suriyapol P, Tahseen S, Tang P, Teo YY, Thuong TNT, Thwaites G, Tortoli E, van Soolingen D, Walker AS, Walker TM, Wilcox M, Wilson DJ, Wyllie D, Yang Y, Zhang H, Zhao Y, Zhu B.

N Engl J Med. 2018 Oct 11;379(15):1403-1415. doi: 10.1056/NEJMoa1800474. Epub 2018 Sep 26.

15.

In vitro approaches for generation of Mycobacterium tuberculosis mutants resistant to bedaquiline, clofazimine or linezolid and identification of associated genetic variants.

Ismail N, Omar SV, Ismail NA, Peters RPH.

J Microbiol Methods. 2018 Oct;153:1-9. doi: 10.1016/j.mimet.2018.08.011. Epub 2018 Aug 28.

PMID:
30165087
16.

Extensively drug-resistant tuberculosis in South Africa: genomic evidence supporting transmission in communities.

Auld SC, Shah NS, Mathema B, Brown TS, Ismail N, Omar SV, Brust JCM, Nelson KN, Allana S, Campbell A, Mlisana K, Moodley P, Gandhi NR.

Eur Respir J. 2018 Oct 18;52(4). pii: 1800246. doi: 10.1183/13993003.00246-2018. Print 2018 Oct.

17.

Prevalence of drug-resistant tuberculosis in South Africa - Authors' reply.

Ismail NA, Omar SV, Mvusi L, Madhi SA.

Lancet Infect Dis. 2018 Aug;18(8):836-837. doi: 10.1016/S1473-3099(18)30422-5. No abstract available.

PMID:
30064675
18.

Spatial Patterns of Extensively Drug-Resistant Tuberculosis Transmission in KwaZulu-Natal, South Africa.

Nelson KN, Shah NS, Mathema B, Ismail N, Brust JCM, Brown TS, Auld SC, Omar SV, Morris N, Campbell A, Allana S, Moodley P, Mlisana K, Gandhi NR.

J Infect Dis. 2018 Nov 5;218(12):1964-1973. doi: 10.1093/infdis/jiy394. Erratum in: J Infect Dis. 2019 Jan 9;219(3):509.

19.

Prevalence of drug-resistant tuberculosis and imputed burden in South Africa: a national and sub-national cross-sectional survey.

Ismail NA, Mvusi L, Nanoo A, Dreyer A, Omar SV, Babatunde S, Molebatsi T, van der Walt M, Adelekan A, Deyde V, Ihekweazu C, Madhi SA.

Lancet Infect Dis. 2018 Jul;18(7):779-787. doi: 10.1016/S1473-3099(18)30222-6. Epub 2018 Apr 21.

20.

Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study.

Zignol M, Cabibbe AM, Dean AS, Glaziou P, Alikhanova N, Ama C, Andres S, Barbova A, Borbe-Reyes A, Chin DP, Cirillo DM, Colvin C, Dadu A, Dreyer A, Driesen M, Gilpin C, Hasan R, Hasan Z, Hoffner S, Hussain A, Ismail N, Kamal SMM, Khanzada FM, Kimerling M, Kohl TA, Mansjö M, Miotto P, Mukadi YD, Mvusi L, Niemann S, Omar SV, Rigouts L, Schito M, Sela I, Seyfaddinova M, Skenders G, Skrahina A, Tahseen S, Wells WA, Zhurilo A, Weyer K, Floyd K, Raviglione MC.

Lancet Infect Dis. 2018 Jun;18(6):675-683. doi: 10.1016/S1473-3099(18)30073-2. Epub 2018 Mar 21. Erratum in: Lancet Infect Dis. 2018 Mar 27;:.

21.

Whole-Genome Sequence of a Mycobacterium goodii Isolate from a Pediatric Patient in South Africa.

Allam M, Joseph L, Ismail F, Said H, Ismail NA, Ismail A, Mtshali S, Mnyameni F, Goussard P, Pekeur JC, Lourens A, Omar SV.

Genome Announc. 2018 Jan 18;6(3). pii: e01478-17. doi: 10.1128/genomeA.01478-17.

22.

Defining Bedaquiline Susceptibility, Resistance, Cross-Resistance and Associated Genetic Determinants: A Retrospective Cohort Study.

Ismail NA, Omar SV, Joseph L, Govender N, Blows L, Ismail F, Koornhof H, Dreyer AW, Kaniga K, Ndjeka N.

EBioMedicine. 2018 Feb;28:136-142. doi: 10.1016/j.ebiom.2018.01.005. Epub 2018 Jan 9.

23.

Draft Genome Sequence of Mycobacterium peregrinum Isolated from an HIV-Positive Patient in South Africa.

Omar SV, Allam M, Joseph L, Mtshali S, Ismail NA, Ismail A.

Genome Announc. 2017 Aug 3;5(31). pii: e00759-17. doi: 10.1128/genomeA.00759-17.

24.

Comparative accuracy of the REBA MTB MDR and Hain MTBDRplus line probe assays for the detection of multidrug-resistant tuberculosis: A multicenter, non-inferiority study.

Havumaki J, Hillemann D, Ismail N, Omar SV, Georghiou SB, Schumacher SG, Boehme C, Denkinger CM.

PLoS One. 2017 Mar 24;12(3):e0173804. doi: 10.1371/journal.pone.0173804. eCollection 2017.

25.

Some Synonymous and Nonsynonymous gyrA Mutations in Mycobacterium tuberculosis Lead to Systematic False-Positive Fluoroquinolone Resistance Results with the Hain GenoType MTBDRsl Assays.

Ajileye A, Alvarez N, Merker M, Walker TM, Akter S, Brown K, Moradigaravand D, Schön T, Andres S, Schleusener V, Omar SV, Coll F, Huang H, Diel R, Ismail N, Parkhill J, de Jong BC, Peto TE, Crook DW, Niemann S, Robledo J, Smith EG, Peacock SJ, Köser CU.

Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e02169-16. doi: 10.1128/AAC.02169-16. Print 2017 Apr.

26.

Transmission of Extensively Drug-Resistant Tuberculosis in South Africa.

Shah NS, Auld SC, Brust JC, Mathema B, Ismail N, Moodley P, Mlisana K, Allana S, Campbell A, Mthiyane T, Morris N, Mpangase P, van der Meulen H, Omar SV, Brown TS, Narechania A, Shaskina E, Kapwata T, Kreiswirth B, Gandhi NR.

N Engl J Med. 2017 Jan 19;376(3):243-253. doi: 10.1056/NEJMoa1604544.

27.

Correlation of rpoB Mutations with Minimal Inhibitory Concentration of Rifampin and Rifabutin in Mycobacterium tuberculosis in an HIV/AIDS Endemic Setting, South Africa.

Rukasha I, Said HM, Omar SV, Koornhof H, Dreyer AW, Musekiwa A, Moultrie H, Hoosen AA, Kaplan G, Fallows D, Ismail N.

Front Microbiol. 2016 Dec 5;7:1947. eCollection 2016.

28.

Evaluation of the GenoType MTBDRsl Version 2.0 Assay for Second-Line Drug Resistance Detection of Mycobacterium tuberculosis Isolates in South Africa.

Gardee Y, Dreyer AW, Koornhof HJ, Omar SV, da Silva P, Bhyat Z, Ismail NA.

J Clin Microbiol. 2017 Mar;55(3):791-800. doi: 10.1128/JCM.01865-16. Epub 2016 Dec 14.

29.

Evaluation of Semiautomated IS6110-Based Restriction Fragment Length Polymorphism Typing for Mycobacterium tuberculosis in a High-Burden Setting.

Said HM, Krishnamani K, Omar SV, Dreyer AW, Sansom B, Fallows D, Ismail NA.

J Clin Microbiol. 2016 Oct;54(10):2547-52. doi: 10.1128/JCM.00408-16. Epub 2016 Aug 3.

30.

Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project.

Zignol M, Dean AS, Alikhanova N, Andres S, Cabibbe AM, Cirillo DM, Dadu A, Dreyer A, Driesen M, Gilpin C, Hasan R, Hasan Z, Hoffner S, Husain A, Hussain A, Ismail N, Kamal M, Mansjö M, Mvusi L, Niemann S, Omar SV, Qadeer E, Rigouts L, Ruesch-Gerdes S, Schito M, Seyfaddinova M, Skrahina A, Tahseen S, Wells WA, Mukadi YD, Kimerling M, Floyd K, Weyer K, Raviglione MC.

Lancet Infect Dis. 2016 Oct;16(10):1185-1192. doi: 10.1016/S1473-3099(16)30190-6. Epub 2016 Jul 7.

31.

Field evaluation of a novel preservation medium to transport sputum specimens for molecular detection of Mycobacterium tuberculosis in a rural African setting.

Omar SV, Peters RP, Ismail NA, Jonkman K, Dreyer AW, Said HM, Gwala T, Ismail N, Fourie PB.

Trop Med Int Health. 2016 Jun;21(6):776-82. doi: 10.1111/tmi.12701. Epub 2016 May 16.

32.

Corrigendum: Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis.

Bradley P, Gordon NC, Walker TM, Dunn L, Heys S, Huang B, Earle S, Pankhurst LJ, Anson L, de Cesare M, Piazza P, Votintseva AA, Golubchik T, Wilson DJ, Wyllie DH, Diel R, Niemann S, Feuerriegel S, Kohl TA, Ismail N, Omar SV, Smith EG, Buck D, McVean G, Walker AS, Peto TE, Crook DW, Iqbal Z.

Nat Commun. 2016 Apr 20;7:11465. doi: 10.1038/ncomms11465. No abstract available.

33.

Multicenter Noninferiority Evaluation of Hain GenoType MTBDRplus Version 2 and Nipro NTM+MDRTB Line Probe Assays for Detection of Rifampin and Isoniazid Resistance.

Nathavitharana RR, Hillemann D, Schumacher SG, Schlueter B, Ismail N, Omar SV, Sikhondze W, Havumaki J, Valli E, Boehme C, Denkinger CM.

J Clin Microbiol. 2016 Jun;54(6):1624-1630. doi: 10.1128/JCM.00251-16. Epub 2016 Apr 13.

34.

A Novel Molecular Strategy for Surveillance of Multidrug Resistant Tuberculosis in High Burden Settings.

Said HM, Kushner N, Omar SV, Dreyer AW, Koornhof H, Erasmus L, Gardee Y, Rukasha I, Shashkina E, Beylis N, Kaplan G, Fallows D, Ismail NA.

PLoS One. 2016 Jan 11;11(1):e0146106. doi: 10.1371/journal.pone.0146106. eCollection 2016.

35.

Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis.

Bradley P, Gordon NC, Walker TM, Dunn L, Heys S, Huang B, Earle S, Pankhurst LJ, Anson L, de Cesare M, Piazza P, Votintseva AA, Golubchik T, Wilson DJ, Wyllie DH, Diel R, Niemann S, Feuerriegel S, Kohl TA, Ismail N, Omar SV, Smith EG, Buck D, McVean G, Walker AS, Peto TE, Crook DW, Iqbal Z.

Nat Commun. 2015 Dec 21;6:10063. doi: 10.1038/ncomms10063. Erratum in: Nat Commun. 2016;7:11465.

36.

Performance evaluation of three commercial molecular assays for the detection of Mycobacterium tuberculosis from clinical specimens in a high TB-HIV-burden setting.

Matabane MM, Ismail F, Strydom KA, Onwuegbuna O, Omar SV, Ismail N.

BMC Infect Dis. 2015 Nov 9;15:508. doi: 10.1186/s12879-015-1229-9.

37.

Optimizing Mycobacterial Culture in Smear-Negative, Human Immunodeficiency Virus-Infected Tuberculosis Cases.

Ismail NA, Said HM, Pinini Z, Omar SV, Beyers N, Naidoo P.

PLoS One. 2015 Nov 6;10(11):e0141851. doi: 10.1371/journal.pone.0141851. eCollection 2015.

38.

Laboratory evaluation of a specimen transport medium for downstream molecular processing of sputum samples to detect Mycobacterium tuberculosis.

Omar SV, Peters RP, Ismail NA, Dreyer AW, Said HM, Gwala T, Ismail N, Fourie PB.

J Microbiol Methods. 2015 Oct;117:57-63. doi: 10.1016/j.mimet.2015.07.010. Epub 2015 Jul 14.

PMID:
26183764
39.

Comparison of Three Commercial Molecular Assays for Detection of Rifampin and Isoniazid Resistance among Mycobacterium tuberculosis Isolates in a High-HIV-Prevalence Setting.

Strydom K, Ismail F, Matabane MM, Onwuegbuna O, Omar SV, Ismail N.

J Clin Microbiol. 2015 Sep;53(9):3032-4. doi: 10.1128/JCM.01691-15. Epub 2015 Jul 1.

40.

Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study.

Walker TM, Kohl TA, Omar SV, Hedge J, Del Ojo Elias C, Bradley P, Iqbal Z, Feuerriegel S, Niehaus KE, Wilson DJ, Clifton DA, Kapatai G, Ip CLC, Bowden R, Drobniewski FA, Allix-Béguec C, Gaudin C, Parkhill J, Diel R, Supply P, Crook DW, Smith EG, Walker AS, Ismail N, Niemann S, Peto TEA; Modernizing Medical Microbiology (MMM) Informatics Group.

Lancet Infect Dis. 2015 Oct;15(10):1193-1202. doi: 10.1016/S1473-3099(15)00062-6. Epub 2015 Jun 23. Erratum in: Lancet Infect Dis. 2017 Nov 21;:.

41.

Molecular detection of Mycobacterium tuberculosis from sputum transported in PrimeStore(®) from rural settings.

Daum LT, Peters RP, Fourie PB, Jonkman K, Worthy SA, Rodriguez JD, Ismail NA, Omar SV, Fischer GW.

Int J Tuberc Lung Dis. 2015 May;19(5):552-7. doi: 10.5588/ijtld.14.0769.

PMID:
25868023
42.

Performance of a Novel Algorithm Using Automated Digital Microscopy for Diagnosing Tuberculosis.

Ismail NA, Omar SV, Lewis JJ, Dowdy DW, Dreyer AW, van der Meulen H, Nconjana G, Clark DA, Churchyard GJ.

Am J Respir Crit Care Med. 2015 Jun 15;191(12):1443-9. doi: 10.1164/rccm.201502-0390OC.

PMID:
25826383
43.

A subset of circulating blood mycobacteria-specific CD4 T cells can predict the time to Mycobacterium tuberculosis sputum culture conversion.

Riou C, Gray CM, Lugongolo M, Gwala T, Kiravu A, Deniso P, Stewart-Isherwood L, Omar SV, Grobusch MP, Coetzee G, Conradie F, Ismail N, Kaplan G, Fallows D.

PLoS One. 2014 Jul 21;9(7):e102178. doi: 10.1371/journal.pone.0102178. eCollection 2014.

44.

Next-generation sequencing for identifying pyrazinamide resistance in Mycobacterium tuberculosis.

Daum LT, Fourie PB, Bhattacharyya S, Ismail NA, Gradus S, Maningi NE, Omar SV, Fischer GW.

Clin Infect Dis. 2014 Mar;58(6):903-4. doi: 10.1093/cid/cit811. Epub 2013 Dec 12. No abstract available.

PMID:
24336821
45.

Comparison between the BACTEC MGIT 960 system and the agar proportion method for susceptibility testing of multidrug resistant tuberculosis strains in a high burden setting of South Africa.

Said HM, Kock MM, Ismail NA, Baba K, Omar SV, Osman AG, Hoosen AA, Ehlers MM.

BMC Infect Dis. 2012 Dec 22;12:369. doi: 10.1186/1471-2334-12-369.

46.

Next-generation ion torrent sequencing of drug resistance mutations in Mycobacterium tuberculosis strains.

Daum LT, Rodriguez JD, Worthy SA, Ismail NA, Omar SV, Dreyer AW, Fourie PB, Hoosen AA, Chambers JP, Fischer GW.

J Clin Microbiol. 2012 Dec;50(12):3831-7. doi: 10.1128/JCM.01893-12. Epub 2012 Sep 12.

47.

Molecular characterization and second-line antituberculosis drug resistance patterns of multidrug-resistant Mycobacterium tuberculosis isolates from the northern region of South Africa.

Said HM, Kock MM, Ismail NA, Mphahlele M, Baba K, Omar SV, Osman AG, Hoosen AA, Ehlers MM.

J Clin Microbiol. 2012 Sep;50(9):2857-62. doi: 10.1128/JCM.00358-12. Epub 2012 May 30.

48.

Evaluation of the GenoType® MTBDRsl assay for susceptibility testing of second-line anti-tuberculosis drugs.

Said HM, Kock MM, Ismail NA, Baba K, Omar SV, Osman AG, Hoosen AA, Ehlers MM.

Int J Tuberc Lung Dis. 2012 Jan;16(1):104-9. doi: 10.5588/ijtld.10.0600.

PMID:
22236854
49.

Analytical performance of the Roche LightCycler® Mycobacterium Detection Kit for the diagnosis of clinically important mycobacterial species.

Omar SV, Roth A, Ismail NA, Erasmus L, Ehlers M, Kock M, Paulse N, Said HM, Hoosen AA, Reischl U.

PLoS One. 2011;6(9):e24789. doi: 10.1371/journal.pone.0024789. Epub 2011 Sep 22.

Supplemental Content

Support Center